Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
21 participants
INTERVENTIONAL
2014-06-30
2017-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Methods: Randomized, single-blind, placebo-controlled cross-over study. Twenty-one enrolled participants who had a diagnosis of breast cancer stage I-IIIA and had completed adjuvant therapy except hormonal treatment. The study consisted of two intervention sessions of 30 minutes separated by a wash-up period of 4 weeks. The interventions consisted of a Myofascial Induction (experimental group) or placebo pulsed shortwave therapy (control group). The main outcome measures were: Visual Analogue Scale for pain and anxiety, shoulder-cervical goniometry for range of motion, Profile of Mood States for psychological distress and Attitudes Toward Massage Scale.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Myofascial Induction session
Patients received a Myofascial Induction focused on the upper limb area for 30 minutes using the Pilat approach.
Myofascial Induction
Patients received a Myofascial Induction focused on the upper limb area for 30 minutes using the Pilat approach.
Placebo session
Patients received a placebo session consisted of 30 minutes of unplugged pulsed shortwave therapy.
Unplugged pulsed shortwave therapy
Patients received a placebo session consisted of 30 minutes of unplugged pulsed shortwave therapy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Myofascial Induction
Patients received a Myofascial Induction focused on the upper limb area for 30 minutes using the Pilat approach.
Unplugged pulsed shortwave therapy
Patients received a placebo session consisted of 30 minutes of unplugged pulsed shortwave therapy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* was between the ages of 25 and 65
* had completed adjuvant therapy except hormonal treatment
Exclusion Criteria
25 Years
65 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad de Granada
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Manuel Arroyo Morales
PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Manuel Arroyo-Morales, PhD
Role: PRINCIPAL_INVESTIGATOR
Deparment of Physical Therapy, Faculty of Health Sciences, University of Granada
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Health Sciences. University of Granada
Granada, , Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Castro-Martin E, Ortiz-Comino L, Gallart-Aragon T, Esteban-Moreno B, Arroyo-Morales M, Galiano-Castillo N. Myofascial Induction Effects on Neck-Shoulder Pain in Breast Cancer Survivors: Randomized, Single-Blind, Placebo-Controlled Crossover Design. Arch Phys Med Rehabil. 2017 May;98(5):832-840. doi: 10.1016/j.apmr.2016.11.019. Epub 2016 Dec 18.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FIS PI10/02749-02764
Identifier Type: -
Identifier Source: org_study_id